| Literature DB >> 22425356 |
Ahmad Zaghal1, Mohamed Khalife, Deborah Mukherji, Nadim El Majzoub, Ali Shamseddine, Jamal Hoballah, Gabriele Marangoni, Walid Faraj.
Abstract
The use of totally implantable venous devices (TIVAD) has changed the care and quality of life for cancer patients, these devices allow chemotherapy administration, and blood sampling without the need for repeated venipuncture. These ports are used mainly when IV access is needed only intermittently over a long period of time. We are presenting a brief overview on TIVADs, with focus on the mid and long-term complications associated with these devices with their management.Entities:
Mesh:
Year: 2012 PMID: 22425356 DOI: 10.1016/j.suronc.2012.02.003
Source DB: PubMed Journal: Surg Oncol ISSN: 0960-7404 Impact factor: 3.279